-
Mashup Score: 2SFH 2025 - Experts Recherche Lymphome - 26 day(s) ago
Le 45 ème congrès de La Société Française d’Hématologie (SFH) se déroulera du 02 avril au 04 avril 2025 au Palais des Congrès de la porte Maillot à Paris. Nous avons le plaisir de vous annoncer que 2 séances ont été programmées par le LYSA lors des trois jours du congrès SFH. Présentation des guidelines – Guillaume Manson Pédiatrie AJA – Aurélie Cabannes-Hamy Sujets âgés – Hervé Ghesquières TEP – Anne-Ségolène Cottereau ctDNA : quelles infos utiles pour la PEC en tirer ? – Cédric Rossi 7 présentations
Source: experts-recherche-lymphome.orgCategories: General Medicine NewsTweet
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
-
Mashup Score: 8ASH 2024 - Experts Recherche Lymphome - 5 month(s) ago
OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA AFTER FAILURE OF ANTI-CD19 CAR T-CELL THERAPY: A DESCAR-T STUDY BY LYSA GROUP. OUTCOMES OF PATIENTS WITH HODGKIN LYMPHOMA RECEIVING BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE THERAPY AFTER ASCT ACCORDING TO PREVIOUS EXPOSURE TO BV. A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY IN COLLABORATION WITH GELTAMO, FIL, LYSARC, AND TURKISH LYMPHOMA GROUP HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME AFTER ANTI-CD19 CAR T-CELLS FOR B-CELL LYMPHOMA AND
Source: experts-recherche-lymphome.orgCategories: General Medicine News, Oncologists1Tweet-
[LYSA presentations] 📢 @ASH_hematology congress start this dec 7th 💡@LYSA will present 9 oral communications and 11 posters Find out more here: https://t.co/TLBvrNYfDs Stay Tuned ! @VincentCamus76 @NicolasGower #LYSA #ASH2024 #Hematology #Lymphoma #ClinicalResearch https://t.co/aH4WO5mKiv
-
[LYSA - SFH 25] 📷 Retour en images sur le 45ème congrès de la SFH. 🌐 Redécouvrez toutes les présentations LYSA ici : https://t.co/arHpS7Iq7Z #SFH25 #lymphoma #study #congress #congres #etudes https://t.co/TmpMoGlMXj